Identification of Concentration Drivers for Male Fetal Free DNA Based on Multiple Linear Regression and Correlation Analysis
DOI:
https://doi.org/10.62051/v47rgf44Keywords:
Non-invasive prenatal testing; Multiple linear regression; Spearman correlation analysis.Abstract
Addressing the challenge that Y-chromosome concentration in male fetuses during non-invasive prenatal testing is influenced by multiple maternal physiological and technical factors, this study utilized data from 1,082 clinical samples to construct a data-driven model for identifying and quantifying concentration drivers. The study first converted text-based gestational age uniformly into days using a gestational age conversion function. Categorical variables such as mode of delivery and parity were encoded using one-hot encoding. Height and weight indicators with severe multicollinearity were excluded using variance inflation factor to ensure independence of model inputs. During modeling, ordinary least squares established a multiple linear regression model. Spearman's rank correlation coefficient and hierarchical clustering were employed to multidimensionally analyze the association characteristics between 22 independent variables and Y chromosome concentration. Results showed the adjusted R² of this regression model was 0.468, with an F-statistic of 40.61, passing the significance test. The study identified the proportion of filtered reads, the proportion of duplicate reads, and X chromosome concentration as core influencing factors. It also quantified the positive promoting effect of gestational age and the negative diluting effect of body mass index. This research provides scientific quantitative evidence for clinically evaluating test reliability and optimizing sampling timing.
Downloads
References
[1] Lin K, Xu J, Su H, et al. A multiplex digital PCR-based all-in-one non-invasive prenatal test for simultaneous detection of Fetal chromosomal aneuploidies and Fetal fraction quantification [J]. Microchemical Journal, 2026, 220116569-11656. DOI: https://doi.org/10.1016/j.microc.2025.116569
[2] Lillie M H, Scherr L C, Ratcliff L C, et al. Expanding the Theory of Persuasive Hope: Identifying Mechanisms of Hope's Effect on Non-Invasive Prenatal Testing Intentions. [J]. Health communication, 2025, 1-11. DOI: https://doi.org/10.1080/10410236.2025.2601803
[3] Zemanick T E, Putra M, Elfman H, et al. Response to Wynn et al. re: "False reassurance following single gene non-invasive prenatal testing for cystic fibrosis". [J]. Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society, 2025. DOI: https://doi.org/10.1016/j.jcf.2025.10.012
[4] Wynn J, Haddad A, Hoskovec J, et al. Response to Zemanick et al., "false reassurance following single gene non-invasive prenatal testing for cystic fibrosis". [J]. Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society, 2025. DOI: https://doi.org/10.1016/j.jcf.2025.12.004
[5] Hu J, Zhang C, Zeng L, et al. Clinical utility and limitations of non-invasive prenatal testing for chromosome 20 abnormalities: A retrospective study of 83 high-risk pregnancies. [J]. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2025. DOI: https://doi.org/10.1002/ijgo.70722
[6] Li T. REGRESSION ANALYSIS-BASED INVESTIGATION OF FACTORS INFLUENCING MALE FETAL Y CHROMOSOME CONCENTRATION AND STRATIFIED OPTIMIZATION OF OPTIMAL TIMING FOR NON-INVASIVE PRENATAL TESTING [J]. Journal of Pharmaceutical and Medical Research, 2025, 7(3). DOI: https://doi.org/10.61784/jpmr3053
[7] Chen R. NON-INVASIVE PRENATAL DETECTION MODEL FOR FEMALE FETAL CHROMOSOMAL ANEUPLOIDY BASED ON XGBOOST [J]. Journal of Pharmaceutical and Medical Research, 2025, 7(3). DOI: https://doi.org/10.61784/jpmr3054
[8] Wu J, Zhang J, Li L, et al. Research on Individualized Decision-Making for Timing of Non-Invasive Prenatal Testing (NIPT) Based on Chance-Constrained Programming and Multifactorial Probabilistic Modeling [J]. Journal of Engineering System, 2025, 3(4). DOI: https://doi.org/10.62517/jes.202502413
[9] Marinho C J, Fadim J, Simões S D R, et al. EE222 Cost-Effectiveness and Budget Impact Analysis of Noninvasive Prenatal Testing (NIPT) for the Identification of Fetal Chromosomal Aneuploidies in Brazilian Private Healthcare System [J]. Value in Health, 2025, 28(12S1): S146-S146. DOI: https://doi.org/10.1016/j.jval.2025.09.606
[10] Keqin J, Xiayuan X, Shuangshuang S, et al. Application of noninvasive prenatal testing-plus in fetal ultrasound cardiovascular abnormalities: An observational study [J]. Medicine, 2025, 104(48): e46108-e46108. DOI: https://doi.org/10.1097/MD.0000000000046108
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Transactions on Materials, Biotechnology and Life Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.






